20(S)-Ginsenoside Rh2 suppresses proliferation and migration of hepatocellular carcinoma cells by targeting EZH2 to regulate CDKN2A-2B gene cluster transcription
Authors:
- 1 November 2017
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 815, 173-180
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81303268)
- Natural Science Foundation of Beijing City (7152098)
This publication has 30 references indexed in Scilit:
- Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcomeCancer, 2011
- MEK–ERK pathway regulates EZH2 overexpression in association with aggressive breast cancer subtypesOncogene, 2011
- Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53Cancer Letters, 2011
- Regulation of chromatin by histone modificationsCell Research, 2011
- DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylationMolecular Cancer Therapeutics, 2009
- Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cellsGenes & Development, 2007
- Treatment of hepatocellular carcinomaCritical Reviews in Oncology/Hematology, 2006
- Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for allNature Reviews Molecular Cell Biology, 2006
- Methylation status of p14ARF, p15INK4b, and p16INK4a genes in human hepatocellular carcinomaLiver International, 2005
- 3-Deazaneplanocin: A new and potent inhibitor of S-adenosylhomocysteine hydrolase and its effects on human promyelocytic leukemia cell line HL-60Biochemical and Biophysical Research Communications, 1986